US Patent 7795313 Bis(thio-hydrazide amide) salts for treatment of cancers
Patent 7795313 was granted and assigned to Synta Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+112 characters)
Article
Patent abstract
Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I):
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Elena Kostik0
Farid Vaghefi0
Guiqing Liang0
Keizo Koya0
Lijun Sun0
Noriaki Tatsuta0
Shoujun Chen0
Takayo Inoue0
Zhi-Qiang Xia0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07795313 Bis(thio-hydrazide amide) salts for treatment of cancers US Patent 7795313 Bis(thio-hydrazide amide) salts for treatment of cancers
Infobox
Patent Number
077953130
Patent Number
77953130
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077953130
Date of Patent
September 14, 2010
0Patent Application Number
125036610
Date Filed
July 15, 2009
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07795313 Bis(thio-hydrazide amide) salts for treatment of cancers
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07795313
Date of patent
September 14, 2010
Patent application number
12503661
Date Filed
July 15, 2009
Patent primary examiner
Find more entities like US Patent 7795313 Bis(thio-hydrazide amide) salts for treatment of cancers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
